Solcoseryl - instructions for use, dose, side effects, contraindications

Auxiliary components: benzalkonium chloride 0.1 mg; carmellose sodium - 13.0 mg; disodium edetate dihydrate 1.0 mg; sorbitol 70% (crystallized) - 50.0 mg; water for injection - up to 1.0 g.

Description:

A colorless or slightly yellowish slightly opalescent flowing gel, odorless or with a weak specific odor.

Pharmacotherapeutic group:Reparation of tissue stimulant

ATX: & nbsp

Other drugs for the treatment of eye diseases

Pharmacodynamics:

The active component of the SOLKOSERIL preparation is a chemically and biologically standardized dialysate containing a wide range of low molecular weight components of the cell mass and serum of dairy calves with a molecular weight up to 5000D (glycoproteins, nucleosides and nucleotides, oligopeptides, amino acids).

Solcoseryl gel eye improves tissue resistance to hypoxia. Activates cellular metabolism by increasing transport and accumulating glucose and oxygen, enhancing intracellular utilization. Thus, the metabolism of ATP is accelerated, the energy resources of the cell are increased.

The healing effect of Solcoseryl is manifested in increased corneal re-epithelialization after the chemical burns (alkali), inflammatory processes, and trauma.

Carmellose sodium, which is part of Solcoseryl gel eye as an auxiliary,provides a uniform and long-term coverage of the cornea, resulting in the active substance continuously enters the affected tissue.

Pharmacokinetics:

Pharmacokinetic characteristics (absorption, spreading, excretion) can not be studied using standard pharmacokinetic methods, since Solcoseryl contains components of blood and substances physiological for the organism.

Indications:

1. Mechanical damage to the cornea and conjunctiva (erosion, trauma), to accelerate the healing process of postoperative corneal scar and conjunctiva in the postoperative period (after keratoplasty, cataract extraction, antiglaucomatous operations).

2. Corneal burns: chemical (exposure to acids and alkalis), thermal, radiation (exposure to UV, X-ray and other radiation).

3. Corneal ulcers, keratitis (bacterial, viral, fungal etiology), including neuroparalytic, in the epithelization stage in combination with antibiotics, antiviral, antifungal drugs.

4. Dystrophies of the cornea of various genesis (including bullous keratopathy).

5. Corneal cornea with lagophthalmos.

6. "Dry" keratoconjunctivitis.

7. To shorten the terms of adaptation to hard and soft contact lenses and improve their portability.

Contraindications:

1. Hypersensitivity to the components of the drug.

2. Pregnancy (due to lack of data on efficacy and safety studies).

3. Age under 1 year (due to lack of data on efficacy and safety studies).

Dosing and Administration:

If the treating physician has not been recommended otherwise, instill 3-4 drops a day on 1 drop of Solcoseryl gel eye in the conjunctival sac until the symptoms disappear completely.

In severe cases, you can instill Solcoseryl gel eye 1 time per hour. With the simultaneous use of eye drops and Solcoseryl eye gel, the gel is applied last and not earlier than 15 minutes after the drops.

To adapt to hard contact lenses, Solkoseryl gel ophthalmic gel should be instilled directly into the conjunctival sac before and after removal of the lens.

When digging in, do not touch the pipette tip with your hands.

It is recommended that the tube be closed immediately after use.

Side effects:

Local reactions are possible: seldom - short-term mild burning, which is not a reason for drug discontinuation; individual allergic reactions.

Overdose:

No toxic effects were observed in the case of an overdose of Solcoseryl gel ocular gel.

Interaction:

Solcoseryl gel eye can be used in combination with most ophthalmic preparations.

The natural metabolites of the Solcoseryl gel ophthalmic product may reduce the effectiveness of locally applied antinucleoside derivatives with virostatic action, such as, for example, acyclovir or idoxuridine.

Special instructions:

Solcoseryl gel eye contains a preservative benzalkonium chloride and trace amounts of p-hydroxybenzoates (E 216 and E 218) and free benzoic acid (E 210) used in the manufacturing process. This fact should be taken into account in the treatment of patients predisposed to an allergic reaction to these components.

Effect on the ability to drive transp. cf. and fur:

Immediately after the application of the drug Solcoseryl gel eye can occur a brief decrease in the clarity of visual perception, therefore,Within 20-30 minutes after applying Solcoseryl gel eye patients should refrain from engaging in potentially hazardous activities (driving, working with machinery, etc.).

Form release / dosage:Eye gel.

Packaging:

Eye gel in aluminum tubes of 5 g. The tube together with the instruction for use is placed in a cardboard box.

Storage conditions:

At a temperature of 15 to 25 ° C.

Keep out of the reach of children.

Shelf life:

3 years from the date of production.

Do not use the product after the expiration date printed on the package.

After opening the tube, the drug is suitable for a month.

Terms of leave from pharmacies:On prescription

Registration number:П N013615 / 02

Date of registration:26.06.2009 / 11.09.2012

The owner of the registration certificate:Meda Pharma GmbH & Co. KGMeda Pharma GmbH & Co. KG Germany

Manufacturer: & nbsp

LEGACY PHARMACEUTICALS SWITZERLAND, GmbH Switzerland

Representation: & nbspMEDA PHARMA LLCMEDA PHARMA LLC

Information update date: & nbsp20.03.2016

Illustrated instructions

Instructions

Solcoseryl (Solcoseryl®)